376 related articles for article (PubMed ID: 20537869)
1. The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes.
Tamburella A; Micale V; Leggio GM; Drago F
Eur Neuropsychopharmacol; 2010 Oct; 20(10):704-13. PubMed ID: 20537869
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats.
Tamburella A; Micale V; Navarria A; Drago F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1205-10. PubMed ID: 19596038
[TBL] [Abstract][Full Text] [Related]
3. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
[TBL] [Abstract][Full Text] [Related]
4. Confirmation of antidepressant potential of the selective beta3 adrenoceptor agonist amibegron in an animal model of depression.
Overstreet DH; Stemmelin J; Griebel G
Pharmacol Biochem Behav; 2008 Jun; 89(4):623-6. PubMed ID: 18358519
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
6. Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test).
Consoli D; Fedotova J; Micale V; Sapronov NS; Drago F
Eur J Pharmacol; 2005 Sep; 520(1-3):100-7. PubMed ID: 16150440
[TBL] [Abstract][Full Text] [Related]
7. Resistance to the development of stress-induced behavioral despair in the forced swim test associated with elevated hippocampal Bcl-xl expression.
Shishkina GT; Kalinina TS; Berezova IV; Bulygina VV; Dygalo NN
Behav Brain Res; 2010 Dec; 213(2):218-24. PubMed ID: 20457187
[TBL] [Abstract][Full Text] [Related]
8. Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection.
Bravo JA; Díaz-Veliz G; Mora S; Ulloa JL; Berthoud VM; Morales P; Arancibia S; Fiedler JL
Behav Pharmacol; 2009 May; 20(3):273-85. PubMed ID: 19424057
[TBL] [Abstract][Full Text] [Related]
9. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain.
Réus GZ; Stringari RB; Ribeiro KF; Ferraro AK; Vitto MF; Cesconetto P; Souza CT; Quevedo J
Behav Brain Res; 2011 Aug; 221(1):166-71. PubMed ID: 21397634
[TBL] [Abstract][Full Text] [Related]
10. Behavioral changes after maternal separation are reversed by chronic constant light treatment.
Dimatelis JJ; Stein DJ; Russell VA
Brain Res; 2012 Oct; 1480():61-71. PubMed ID: 22975437
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.
Stemmelin J; Cohen C; Terranova JP; Lopez-Grancha M; Pichat P; Bergis O; Decobert M; Santucci V; Françon D; Alonso R; Stahl SM; Keane P; Avenet P; Scatton B; le Fur G; Griebel G
Neuropsychopharmacology; 2008 Feb; 33(3):574-87. PubMed ID: 17460614
[TBL] [Abstract][Full Text] [Related]
12. The hydrophobic dipeptide Leu-Ile inhibits immobility induced by repeated forced swimming via the induction of BDNF.
Furukawa-Hibi Y; Nitta A; Ikeda T; Morishita K; Liu W; Ibi D; Alkam T; Nabeshima T; Yamada K
Behav Brain Res; 2011 Jul; 220(2):271-80. PubMed ID: 21315766
[TBL] [Abstract][Full Text] [Related]
13. Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB.
Xu Y; Ku B; Tie L; Yao H; Jiang W; Ma X; Li X
Brain Res; 2006 Nov; 1122(1):56-64. PubMed ID: 17022948
[TBL] [Abstract][Full Text] [Related]
14. Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment.
Larsen MH; Mikkelsen JD; Hay-Schmidt A; Sandi C
J Psychiatr Res; 2010 Oct; 44(13):808-16. PubMed ID: 20172535
[TBL] [Abstract][Full Text] [Related]
15. Involvement of serotonin receptor subtypes in the antidepressant-like effect of beta receptor agonist Amibegron (SR 58611A): an experimental study.
Tanyeri P; Buyukokuroglu ME; Mutlu O; Ulak G; Yıldız Akar F; Komsuoglu Celikyurt I; Erden BF
Pharmacol Biochem Behav; 2013 Apr; 105():12-6. PubMed ID: 23380524
[TBL] [Abstract][Full Text] [Related]
16. Implication of beta3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stress.
Stemmelin J; Cohen C; Yalcin I; Keane P; Griebel G
Behav Brain Res; 2010 Jan; 206(2):310-2. PubMed ID: 19744528
[TBL] [Abstract][Full Text] [Related]
17. Behavioural and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant.
Tamburella A; Leggio GM; Micale V; Navarria A; Bucolo C; Cicirata V; Drago F; Salomone S
Int J Neuropsychopharmacol; 2013 May; 16(4):813-23. PubMed ID: 22695046
[TBL] [Abstract][Full Text] [Related]
18. Effects of analgesic or antidepressant drugs on pain- or stress-evoked hippocampal and spinal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression in the rat.
Duric V; McCarson KE
J Pharmacol Exp Ther; 2006 Dec; 319(3):1235-43. PubMed ID: 16956981
[TBL] [Abstract][Full Text] [Related]
19. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
Butterweck V; Winterhoff H; Herkenham M
Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
[TBL] [Abstract][Full Text] [Related]
20. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels.
Garcia LS; Comim CM; Valvassori SS; Réus GZ; Andreazza AC; Stertz L; Fries GR; Gavioli EC; Kapczinski F; Quevedo J
Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):502-6. PubMed ID: 19067677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
